EDGAR Filing Documents for 0001737287-22-000028

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001737287-22-000028

Filing Date

2022-04-26

Accepted

2022-04-26 16:35:40

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	allo-20220426xdefa14axnoti.htm	DEFA14A	11505
2		noticecard1.jpg	GRAPHIC	152979
3		noticecard2.jpg	GRAPHIC	132491
	Complete submission text file	0001737287-22-000028.txt		405821

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080

Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700

Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38693 | Film No.: 22854870
SIC: 2836 Biological Products, (No Diagnostic Substances)